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Abstract
Cytokines such as TNF and FASL can trigger death or survival depending on cell lines and cellular conditions. The
mechanistic details of how a cell chooses among these cell fates are still unclear. The understanding of these processes is
important since they are altered in many diseases, including cancer and AIDS. Using a discrete modelling formalism, we
present a mathematical model of cell fate decision recapitulating and integrating the most consistent facts extracted from
the literature. This model provides a generic high-level view of the interplays between NFkB pro-survival pathway, RIP1-
dependent necrosis, and the apoptosis pathway in response to death receptor-mediated signals. Wild type simulations
demonstrate robust segregation of cellular responses to receptor engagement. Model simulations recapitulate documented
phenotypes of protein knockdowns and enable the prediction of the effects of novel knockdowns. In silico experiments
simulate the outcomes following ligand removal at different stages, and suggest experimental approaches to further
validate and specialise the model for particular cell types. We also propose a reduced conceptual model implementing the
logic of the decision process. This analysis gives specific predictions regarding cross-talks between the three pathways, as
well as the transient role of RIP1 protein in necrosis, and confirms the phenotypes of novel perturbations. Our wild type and
mutant simulations provide novel insights to restore apoptosis in defective cells. The model analysis expands our
understanding of how cell fate decision is made. Moreover, our current model can be used to assess contradictory or
controversial data from the literature. Ultimately, it constitutes a valuable reasoning tool to delineate novel experiments.
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Introduction
Engagement of TNF or FAS receptors can trigger cell death by
apoptosis or necrosis, or yet lead to the activation of pro-survival
signalling pathway(s), such as NFkB. Apoptosis represents a tightly
controlled mechanism of cell death that is triggered by internal or
external death signals or stresses. This mechanism involves a
sequence of biochemical and morphological changes resulting in
the vacuolisation of cellular content, followed by its phagocyte-
mediated elimination. This physiological process regulates cell
homeostasis, development, and clearance of damaged, virus-
infected or cancer cells. In contrast, pathological necrosis results in
plasma membrane disruption and release of intracellular content
that can trigger inflammation in the neighbouring tissues. Long
seen as an accidental cell death, necrosis also appears regulated
and possibly involved in the clearance of virus-infected or cancer
cells that escaped apoptosis [1].
Dynamical modelling of the regulatory network controlling
apoptosis, non-apoptotic cell death and survival pathways could
help identify how and under which conditions the cell chooses
between different types of cellular deaths or survival. Moreover,
modelling could suggest ways to re-establish the apoptotic death
when it is altered, or yet to trigger necrosis in apoptosis-resistant
cells. The decision process involves several signalling pathways, as
well as multiple positive and negative regulatory circuits.
Mathematical modelling provides a rigorous integrative approach
to understand and analyse the dynamical behaviours of such
complex systems.
Published models of cell death control usually focus on one
death pathway only, such as the apoptotic extrinsic or intrinsic
pathways [2,3,4]. A few studies integrate both pathways [5], some
show that the concentration of specific components contribute to
the decision between death and survival [6,7] while other studies
investigate the balance between proliferation, survival or apoptosis
in specific cell types along with the role of key components in these
pathways [8], but no mathematical models including necrosis are
available yet. Moreover, we still lack models properly demonstrat-
ing how cellular conditions determine the choice between necrosis,
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apoptosis and survival, and how and to what extent conversions
are allowed between these fates.
Our study aims at identifying determinants of this cell fate
decision process. The three main phenotypes considered are
apoptosis, non-apoptotic cell death (which mainly covers necrosis) and
survival. Although the pathways leading to these three phenotypes
are highly intertwined, we first describe them separately hereafter,
concentrating on the players we chose to include in each pathway.
Summarised in Figure 1A, this description does not intend to be
exhaustive, but rather aims at covering the most established
processes participating in cell fate decision.
Caspase-dependent apoptotic cell death
Only the apoptotic caspase-dependent pathway downstream of
FAS and TNF receptors is considered here. Upon engagement by
their ligands and in the presence of FADD (FAS-Associated
protein with Death Domain), a specific Death Inducible Signalling
Complex (DISC-FAS or DISC-TNF in Figure 1) forms and
recruits pro-caspase-8. This leads to the cleavage and activation of
caspase-8 (CASP8). In the so-called type II cells, CASP8 triggers
the intrinsic or mitochondria-dependent apoptotic pathway, which
also responds to DNA damage directly through the p53-mediated
chain of events (not detailed here). CASP8 cleaves the BH3-only
protein BID (not explicitly included in the diagram), which can
then translocate to the mitochondria outer membrane. There,
BID competes with anti-apoptotic BH3 family members such as
BCL2 for interaction with the proteins BAX or BAK (BAX will
stand here for both BAX and BAK). Consequently, oligomerisa-
tion of BAX results in mitochondrial outer membrane permea-
bilisation (MOMP) and the release of pro-apoptotic factors. Once
released to the cytosol, cytochrome c (Cyt_c) interacts with
APAF1, recruiting pro-caspase-9. In presence of dATP, this
enables the assembly of the apoptosome complex (referred to as
‘Apoptosome’ in Figure 1A, lumping APAF1 and pro-caspase-9),
responsible for caspase-9 activation, followed by the proteolytic
activation of pro-caspase-3 (CASP3) [9]. By cleavage of specific
targets, the executioner caspases (CASP3 in the model) are
responsible for major biochemical and morphological changes
characteristic of apoptosis. SMAC/DIABLO (SMAC) is released
during MOMP to the cytosol, where it is able to inactivate the
caspase inhibitor XIAP [10]. CASP3 also participates in a positive
circuit by inducing the activation of CASP8 [11,12]. In type I cells,
CASP8 directly cleaves and activates executioner caspases such as
CASP3 (not described).
Non-apoptotic cell death (NonACD)
Here, we consider mainly a mode of cell death with
morphological features of necrosis, which occurs when apoptosis
is impeded in cells treated with cytokines [13] or in some specific
cell lines such as L929 cells when exposed to TNF [14]. In primary
T cells, if caspases are inhibited, activation of TNFR or FAS
causes necrosis via a pathway that requires the protein RIP1 and
its kinase activity (RIP1K) [13]. This RIP1-dependent cytokine-
induced necrotic death defines necroptosis [15,16]. A genetic
screen recently identified other genes necessary for this type of cell
death [17]. However, a precise description of this pathway is still
lacking. Reactive oxygen species (ROS) were proposed to be
involved downstream of RIP1 [18]. ROS are also thought to play
a key role in the control of mitochondria permeability transition
(MPT), since they are produced by damaged mitochondria and
can oxidize mitochondrial components, thus favouring MPT
[19,20,21]. Furthermore, the role of mitochondria in necrosis is
highlighted through the involvement of MPT, which causes a fatal
drop in ATP level and leads to necrotic death. Indeed, MPT
results from the inhibition of ATP/ADP exchange at the level of
mitochondrial membranes, or from the inhibition of oxidative
phosphorylation decreasing cellular ATP level and causing energy
failure [21,22]. Although there is evidence that necrosis is also
triggered by TNF- and FAS-independent pathways, these are not
yet considered in this study. These pathways include, for example,
calpain-mediated cleavage of AIF followed by its nuclear
translocation [23,24], or PARP-1-mediated NAD+ depletion
[24,25].
Survival pathway
NFkB represents a family of transcription factors that play a
central role in inflammation, immune response to infections and
cancer development [26]. The ubiquitination of RIP1 at lysine 63
by cIAP leads to the activation of IKK and ultimately that of
NFkB [27]. In different cell types, especially in tumour cell lines,
activation of NFkB inhibits TNF-induced cell death [28]. This
effect is mediated by NFkB target genes: cFLIP inhibits
recruitment of CASP8 by FADD [29]; anti-apoptotic BCL2
family members inhibit MOMP and MPT [30,31,32]; XIAP acts
as a caspase inhibitor [33]; and ferritin heavy chain [34] or
mitochondrial SOD2 [35] decrease ROS levels (these mechanisms
are represented in Figure 1A by a direct inhibitory arrow from
NFkB to ROS). For the sake of simplicity, other NFkB target
genes that are known to inhibit TNF-induced apoptosis are
provisionally omitted in the model (e.g., A20; cf. [36,37]).
Our goal here is to provide a simplified but yet rigorous model
of the mechanisms underlying cell fate selection in response to the
engagement of FAS and TNF receptors. We have proceeded in
several steps. First, we have assembled a regulatory network
covering the main experimental data. Species and interactions
were selected on the basis of an extensive literature search and
integrated in the form of a diagram or ‘‘regulatory graph’’. This
diagram is then translated into a dynamical model. Our analysis
initially focuses on the determination of the asymptotic properties
of the system for different conditions, which correspond to the
possible phenotypes that the model can account for. Next, we
Author Summary
Activation of death receptors (TNFR and Fas) can trigger
either survival or cell death according to the cell type and
the cellular conditions. In other words, the same signal can
have antagonist responses. On one hand, the cell can
survive by activating the NFkB signalling pathway. On the
other hand, it can die by apoptosis or necrosis. Apoptosis
is a suicide mechanism, i.e., an orchestrated way to disrupt
cellular components and pack them into specialized
vesicles that can be easily removed from the environment,
whereas necrosis is a type of death that involves release of
intracellular components in the surrounding tissues,
possibly causing inflammatory response and severe injury.
We, biologists and theoreticians, have recapitulated and
integrated known biological data from the literature into
an influence diagram describing the molecular events
leading to each possible outcome. The diagram has been
translated into a dynamical Boolean model. Simulations of
wild type, mutant cells and drug treatments qualitatively
match current data, and predict several novel mutant
phenotypes, along with general characteristics of the cell
fate decision mechanism: transient activation of some key
proteins in necrosis, mutual inhibitory cross-talks between
the three pathways. Our model can further be used to
assess contradictory data and address specific biological
questions through in silico experiments.
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Figure 1. Regulatory networks of cell-fate decision. (A) Master model: the molecular interactions between the main components intervening
in the three pathways are described as an influence graph leading to the three cell fates: survival, non-apoptotic cell death and apoptosis. Dashed
lines denote the pathway borders. (B) The corresponding reduced model.
doi:10.1371/journal.pcbi.1000702.g001
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analyse the different trajectories leading to each phenotype in the
wild type and mutant situations. As quantitative data are still
largely lacking for this system, we use a qualitative logical
formalism and its implementation in the GINsim software [38].
As we shall see, proper model analysis can assess where and when
cell fate decisions are made, provide novel insight concerning the
general structure of the network, in particular concerning the
occurrence of cross-talks between pathways, and predict novel
mutant phenotypes and component activity patterns.
Results
The information gathered in the literature has been integrated
into a regulatory graph (Figure 1A). Our selection of molecular
players (nodes of the graph) is based on our current understanding
of the molecular mechanisms of cell fate decision. Documented
positive or negative effects among pairs of components are repre-
sented by signed arcs (Figure 1). Each node or arc is annotated
and associated with bibliographical references in the model file, as
well as in the accompanying documentation (cf. supplementary
Text S1).
Our current model encompasses three main pathways (Figure 1A):
the activation of a caspase-dependent apoptosis pathway, the RIP1-
kinase-dependent pathway leading to necrosis, and the activation of
the transcription factor NFkB with pro-survival effects. Other
pathways involved in cell death, such as growth factor receptors or
other RTK (receptor tyrosine kinase), TLR (Toll-like receptor), and
MAPK signalling pathways have been provisionally left out.
We defined specific ‘‘markers’’ or ‘‘read-outs’’ of the three cell
fates. When caspase-3 is activated, the cells are considered to be
apoptotic; when MPT occurs and the level of ATP drops
dramatically, the cells enter non-apoptotic cell death; finally,
when NFkB is activated, we consider that cells survive. Active
survival is thus monitored here by the activation of NFkB
pathway, in accordance with many studies, as opposed to passive
survival, which occurs when no death signals are engaged. In
reality, other pathways can interact downstream of NFkB
activation, which can reinforce or shut off survival. For now,
passive survival will be referred to as the ‘naı¨ve’ state, i.e. the stable
states with none of the three pathways activated.
Cross-talks between the three pathways
As mentioned before, the pathways are highly intertwined
(Figure 1A). For instance, the survival pathway interacts with the
apoptotic pathway at different points: cFLIP inhibits CASP8;
BCL2 blocks mitochondria pore opening through inhibition of
BAX (and BAK, implicitly represented in our model); and XIAP
blocks the activity of both CASP9 in the apoptosome and CASP3.
Conversely, the apoptotic pathway negatively regulates NFkB
activity through the CASP8-mediated cleavage and inactivation of
RIP1 upstream of NFkB. Because RIP1 operates upstream of the
necrotic pathway, this regulation also impacts necrosis. Moreover,
for the apoptosome to form, dATP (or/and ATP) is (/are) needed.
Consequently, in our model, when necrosis occurs, ATP pro-
duction drops, terminating apoptosis. Regarding the influence of
the survival pathway on the necrotic one, NFkB tentatively
stimulates the production of anti-oxidants that shuts off ROS level.
Both the necrotic and the apoptotic pathways are able to interact
with the survival pathway through the action of cIAP1/2, referred
to as cIAP in our model. More precisely, cIAP1 and 2 are E3-
ubiquitin ligases that target RIP1 for K63-linked polyubiquitina-
tion. They are essential intermediates in the activation of NFkB
downstream of TNF receptor [27]. Some synthetic molecules that
mimic the N-terminal of SMAC IAP-interacting motif have been
shown to induce cIAP1/2 auto-ubiquitination and subsequent
proteasomal degradation, thus blocking TNF-dependent NFkB
activation [39,40]. Tentatively, mitochondrial permeabilization in
the apoptosis or necrosis pathways could block TNF-induced NFkB
activation through the release of SMAC into the cytosol thereby
causing the inhibition of c-IAP1/2. Initially, cIAP was not included
in the model, which led to discrepancies between model simulations
and published data. Indeed, in FADD or CASP8 deletion mutants,
our preliminary model predicted only survival (not shown), whereas
both necrotic and survival phenotypes were observed in experi-
ments in the presence of TNF or FAS [41,42,43]. The consideration
of the path MOMP)SMAC=|cIAP)NFkB enabled us to
eliminate the discrepancies, both necrotic and survival phenotypes
were then obtained in the simulations, although it does not preclude
other mechanisms.
Dynamical logical model of cell fate decision
To transform the static map shown in Figure 1A into a
dynamical model accounting for the different scenarios or set of
events leading to one of the three phenotypes, we have to define
proper dynamical rules. Since there is little reliable quantitative
information on reaction kinetics and cellular conditions leading to
one or another phenotype, these rules must be sufficiently flexible
to cover all possible scenarios following death receptor activation.
The nodes encompassed in the map represent different things:
simple biochemical components (receptors, ligands, proteins or
metabolites): TNF, FASL, TNFR, FADD, FLIP, CASP8, RIP1,
IKK, NFkB, cIAP, BCL2, BAX, Cyt_c, SMAC, ROS, XIAP,
CASP3, ATP); specific modified forms of proteins: RIP1K (active
RIP1 kinase), RIP1ub (K63-ubiquitinated RIP1); complexes of
proteins: DISC-TNF (corresponding to TRADD, TRAF2, FADD,
proCASP8), DISC-FAS (corresponding to FAS, FADD, pro-
CASP8), apoptosome; cellular processes: MPT (Mitochondrial
Permeability Transition) and MOMP (Mitochondria Outer
Membrane Permeabilisation).
A Boolean variable is associated with each of these nodes, which
can take only two logical values: ‘‘0’’ (false), denoting the absence
or inactivity of the corresponding component, and ‘‘1’’ (true),
denoting its active state.
Furthermore, a logical rule (or function) is assigned to each
node, defining how the different inputs (incoming arrows) combine
to control its level of activation. For example, CASP8 can be
activated (its value is set to ‘‘1’’) by DISC-TNF or DISC-FAS, but
only in the absence of cFLIP protein. This can be encoded into a
logical rule as follows: (DISC-TNF OR DISC-FAS) AND NOT
cFLIP. Several nodes correspond to simple inputs (TNF, FASL
and FADD). Their initial values are kept fixed during most
simulations.
On the basis of the regulatory graph and the associated logical
rules, we then proceeded with the exploration of the dynamical
properties of our model. We first focused on the identification of
all stable states and on their biological interpretation. Then, we
investigated the reachability of these stable states for different
initial conditions, for both wild type and mutant cases. Details on
the computational methods used are provided in the Methods
section and in the supplementary Text S1. The logical model has
been filed in the BioModels database with the reference
MODEL0912180000.
Identification of stable states
Analysis of the cell fate decision model (Figure 1A) led to the
identification of the 27 stable states showed in Figure 2. These
stable states are the sole attractors of the system under the
asynchronous assumption (see Methods). They thus represent all
Mathematical Model of Cell Fate Decision
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possible cellular asymptotical states. In other words, whatever the
initial conditions, a wild type cell will end up in one of these states
if we wait long enough. A closer look reveals that several stable
states correspond to each cellular fate, with few differing (minor)
component values.
This consideration led us to address the following questions: (i)
Does a cluster structure exist in the distribution of internal stable
states of the network? (ii) If so, in these clusters, could the
corresponding states be interpreted as slightly different realisations
of the same cellular phenotype? (iii) What would be the char-
acteristic signature of each cluster (conserved values of variables
inside each cluster)? (iv) What is the number of independent
variables defining the internal stable states of the network?
Standard statistical methods and clustering algorithms are
applied to group stable states. Figure 3 displays a projection of the
internal (without inputs and outputs) stable values into the 2D
space defined by the first two principal components of the
corresponding distribution. The first two principal components
explain 52% and 20% of the total variation, respectively (Table
S1). The first principal component can be associated with the
activity of NFkB pathway, while the second is determined mainly
by ATP and MPT status. These factors do appear to determine
the principal (independent) degrees of freedom for the internal
state of the network. A typical trajectory starting from any set of
initial conditions will thus quickly converge to the region under the
influence of these three components.
The 2-D graph (Figure 3) reveals a striking separation of the
stable states into 4 clusters: one cluster (blue circles) devoid of
significant activity, which we call the ‘naı¨ve’ state; one cluster
(green rhombs) corresponding to survival, with NFkB pathway
activated; and two clusters corresponding to the two different
modalities of cell death, apoptosis (orange squares) and necrosis
(purple triangles). K-means clustering using Euclidean and L1
distance perfectly reproduces these groupings, demonstrating that
the compact groups easily distinguishable on the PCA plot indeed
represent well-separated clusters in the original multidimensional
space.
Some interesting conclusions and predictions can be drawn just
by looking at the values of each component in each phenotypical
group. For instance, in the necrotic (purple) stable states, when
FADD is present (i.e. normal wild type conditions), RIP1 is always
OFF and CASP8 ON, even though RIP1 is required and CASP8
is dispensable for necrosis to occur. This observation suggests a
transient activation of RIP1 protein when switching on the
necrotic pathway in response to death receptors. However,
inactivation or cleavage of RIP1 is not per se a prerequisite for
necrosis, nor is CASP8 activation. Indeed, for the mutant models
in which CASP8 activation is impaired, such as CASP8 or FADD
deletion, there exist necrotic attractors with RIP1= 1 (not shown).
Our model thus predicts that TNF-induced necrosis could occur
despite CASP8-mediated cleavage of RIP1. An attractive
experimental model in which such a transient activation of RIP1
could be tested is the mouse fibrosarcoma cell line L929. Upon
TNF exposure, these cells die by necrosis [44] and they have a
functional CASP8 [45], which is cleaved during TNF-induced cell
death [46].
Since RIP1 controls both the activation of NFkB and the level
of ROS, the same transient behaviour could be expected for the
survival phenotype. However, this is not observed with our model,
as RIP1= 1 in all survival (green) stable states. This can be
explained by the regulatory circuit involving RIP1 and NFkB,
which is not functional in necrosis. Indeed, when NFkB is active, it
can mediate the synthesis of cFLIP, an inhibitor of CASP8, itself
an inhibitor of RIP1. Moreover, RIP1 is part of the positive circuit
that keeps NFkB ON. The model thus suggests that a sustained
RIP1 activity is needed for survival. How could this hypothesis be
experimentally assessed? If an experiment would reveal that RIP1
is only transiently activated upon death receptor activation, while
NFkB remains activated, the model would be contradicted. In that
case, one would need to look for other components capable to
maintain NFkB active.
Model reduction and dynamical analysis
The stable state analysis described above provides a first validation
of the master model presented in Figure 1A. On this basis, we
performed a more detailed analysis of the dynamics of the system.
We investigated which cell fates (stable states) can be reached from
specific initial conditions. Given a set of reachable stable states, can
we say something about their relative ‘‘attractivity’’?
To avoid the combinatorial explosion of the number of states to
consider, we have reduced the number of components while
preserving the relevant dynamical properties of the master model
(Figure 1B). Details of how this reduction is performed are
provided in the Methods section. The resulting network en-
compasses 11 components. The corresponding Boolean rules are
listed in Table 1. The size of the transition graph (211=2048) is
now amenable to a detailed dynamical analysis. First, the set of
attractors of this reduced model is identified: 13 attractors are
obtained, which are all stable states matching those found for the
master model when the input variable FADD=1. Recall that, in
Figure 2. Stable states of the master model. values 0 and 1 are
represented by empty and full circles, respectively.To compare these
stable states to those of the simplified model, the values of FADD=0
need to be deleted since FADD is not explicitly presented in the
reduced model. The first six rows (with NonACD=0, Apoptosis = 0,
Survival = 0) correspond to the ‘‘naı¨ve’’ state. The following five rows
(with NonACD=0, Apoptosis = 0, Survival = 1) correspond to ‘survival’.
The following eight rows (with NonACD= 0, Apoptosis = 1, Survival = 0)
correspond to ‘apoptosis’. The last eight rows (with NonACD= 1,
Apoptosis = 0, Survival = 0) correspond to ‘necrosis’.
doi:10.1371/journal.pcbi.1000702.g002
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the master model, both values of FADD were considered leading
to 13 stable states with FADD=1 and 14 stable states with
FADD=0. Using the theoretical results presented in [47] (mainly
Theorem 1), we can conclude that the 13 stable states of Figure 2
are the only attractors of the master model when FADD=1.
Logical definition of ‘‘mutants’’
Based on the reduced model defined in Figure 1B and Table 1,
we derived 15 model variants representing biologically plausible
perturbations. We will abusively use the term ‘‘mutant’’ to refer to
these variants, even though they do not all technically correspond
to mutations. For instance, the ‘‘z-VAD mutant’’ simulates the
effect of caspase inhibitor z-VAD-fmk. Each mutant simulation
consists in a local alteration of our reduced model, which can be
qualitatively compared with results reported in the literature.
In the Boolean framework, such alterations amount to force the
level of certain variables to zero in the case of a gene deletion, or to
one in the case of a component over-expression. As we are using
the reduced version of the master model, some perturbed
components may be hidden by the reduction process. In such
cases, we change the logical rules of their (possibly indirect) targets
to take into account their effects. Table 2 lists the 15 variants of the
model considered, along with the modified logical rules, the
expected effects on the phenotypes according to the literature, and
short descriptions of simulation results.
Computation of reachable attractors
The references provided in Table 2 cover experiments
performed on different cell types and with different experimental
conditions. In contrast, our cell fate model represents mechanisms
of cell fate decision in a generic cell, qualitatively recapitulating a
wide variety of cellular contexts. Given a cellular system, its
response to the activation of death receptors is determined by the
logical rules. However, the generic model presented here considers
equally all possible contexts and regulatory combinations. To
evaluate the relative likelihood of having a particular response in a
randomly chosen cellular system, we count the relative number of
possible trajectories from the stimulated ‘naı¨ve’ state to a given
phenotype. This analysis gives an idea on what is possible or
forbidden in a ‘generic’ cell.
Using dedicated methods and software [48], the set of reachable
stable states is calculated, starting from selected physiological
initial conditions, for the wild type and mutant models. The
physiological state is defined by fixing the variables ATP and cIAP
Figure 3. Projection of the internal stable state values onto the first two principal components. Four clusters are formed: the ‘naı¨ve’
cluster (round light blue circles) at the center; the survival cluster (green rhombs) characterised by high level of NFkB and related (see Table S1 for
details); the apoptosis cluster (orange squares) characterised by high levels of MOMP, Cyt_c, SMAC and ATP; and the non-apoptotic cell death - or
necrosis - cluster (purple triangles) with high levels of MPT, ROS, MOMP, Cyt_c and SMAC. In the latter three clusters, there are three subgroups of
stable states which correspond to the different inputs of the system: top stable states correspond to high TNF and FAS signals, middle stable states
have either one or the other signal while the lower ones have no inputs. As for the naive cluster, the two sets of stable states differ by their cIAP value.
Inputs and outputs are not included in the stable state binary vector.
doi:10.1371/journal.pcbi.1000702.g003
Table 1. Logical rules associated with the wild type reduced
model.
Node Logical update rule
TNF ( INPUT NODE)
FAS ( INPUT NODE)
RIP19 NOT C8 AND (TNF OR FAS)
NFkB9 (cIAP AND RIP1) AND NOT C3
C89 (TNF OR FAS OR C3) AND NOT NFkB
cIAP9 (NFkB OR cIAP) AND NOT MOMP
ATP9 NOT MPT
C39 ATP AND MOMP AND NOT NFkB
ROS9 NOT NFkB AND (RIP1 OR MPT)
MOMP9 MPT OR (C8 AND NOT NFkB)
MPT9 ROS AND NOT NFkB
doi:10.1371/journal.pcbi.1000702.t001
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to ‘‘1’’ and all the other ones to ‘‘0’’. Different combinations of
TNF and FASL are considered. The probability to reach each
phenotype is computed as a fraction of the paths in the graph that
link physiological initial conditions to each cell fate (Figure 4 for
reduced model and Figure S4 for master model).
As expected, the absence of TNF and FASL can only lead to the
‘naı¨ve’ state (except of course when caspase-8 or NFkB are over-
expressed, for obvious reasons). This means that the inputs (TNF
and FASL) are needed for the system to effectively trigger the
decision process. This was expected since intracellular death
signals are not yet taken into account in the model. When TNF=1
(Figure 4, right panel), for the wild type system, we observe that
three outcomes or phenotypes are reachable from the initial
condition, with different probabilities: ,10% for necrosis, ,30%
for active survival and ,60% for apoptosis. Although these
probabilities cannot be directly compared with experimental
results, they become useful when comparing different variants of
the model. For instance, an increase (or decrease) of a phenotype
probability between the wild type and a particular mutant can be
interpreted as a gain (or a loss) of effectiveness of the
corresponding pathway in that mutant. Such qualitative observa-
tions can then be confronted with published experimental results,
which are summarized in the last column of Table 2.
In most cases, activation of FASL and TNF lead to similar
effects (not shown), except in the case of the FADD deletion mutant
(Figure 5). As expected, this mutant cannot lead to cell death when
FASL is ON. In contrast, necrosis is still possible in the presence of
TNF. Interestingly, TNF-induced apoptosis is expected to be
blocked [49] whereas the qualitative analysis shows that apoptosis
is actually reachable in the model. Nevertheless, the probability of
this phenotype is very low (around 0.61%), which means that very
few trajectories may lead to apoptosis and it would thus be difficult
to obtain the corresponding cellular context.
Variation of the duration of receptor activation and its
effects
In the reachability analysis presented above, the value of TNF
and FASL are kept constant and therefore always ON (or always
OFF) along all trajectories. These qualitative simulations are useful
to characterize the asymptotic behaviour of the system when the
death receptor is engaged for a sufficiently long time. The
principle of ‘ligand removal’ experiments consists in characterizing
the decision process when it is subject to a temporary pulse of
TNF. Here, time is intrinsically discrete, meaning that the
duration of TNF pulse denoted td is represented by an integer
Table 2. Description of the different ‘‘mutant’’ versions of the reduced model.
Name Modified rules Expected phenotypes Qualitative results
Anti-oxidant ROS9= (RIP1 OR MPT) Prediction. Suppression of NFkB anti-oxidant effect leads to no change
in the decision process.
APAF1 deletion C39=0 APAF12/2 mouse thymocytes are not impaired in
FAS-mediated apoptosis ([71]).
Apoptosis disappears and replaced by the naı¨ve state.
Necrosis and survival are close to the wild type case situations.
BAX deletion MOMP9=MPT BAX deletion blocks FAS or TNF+CHX - induced
apoptosis in some cell lines, such as HCT116 [72].
BAX deletion prevents apoptosis.
BCL2 over-
expression
MOMP9=MPT
MPT9=0
FAS induces the activation of NFkB pathway [29]. As expected, the survival and naive attractors are preserved
while both death pathways are inhibited.
CASP8 deletion C89=0 Caspase-8 deficient MEFs [41] or Jurkat cells [42]
are resistant to FAS-mediated apoptotic cell death.
Apoptosis disappears. Compared to the wild type, a slight
increase of necrosis is observed, while survival becomes the
main cell fate.
constitutively
activated CASP8
C89=1 Prediction. Over-expression of caspase-8 leads to a loss of NFkB activation.
cFLIP deletion C89=TNF OR FAS OR C3 cFLIP2/2 MEFs are highly sensitive to FASL and
TNF [73].
The increase of apoptosis is effectively observed in the cFLIP
mutant; furthermore survival can no longer be sustained.
cIAP deletion cIAP9=0 NFkB activation in response to TNF is blocked [53]. NFkB activation is impaired, and only the apoptotic and
necrotic attractors can be reached.
FADD deletion C89=C3 AND NOT NFkB
RIP19=NOT C8 AND TNF
FADD2/2 mouse thymocytes are resistant to FAS
mediated apoptosis [74]. FADD2/2 MEFs are resistant
to FASL and TNF [75]. In Jurkat cells treated with
TNF+CHX, apoptosis is turned into necrosis [43].
FASL signalling is blocked and the ‘naı¨ve’ attractor is the only
reachable one. In response to TNF, apoptosis disappears.
NFkB deletion NFkB9=0 TNF induces both apoptosis and necrosis in
NF-kB p652/2 cells [76] or in IKKb2/2 fibroblasts [35].
This mutant shows a strong increase of necrosis (to be related
with concomitant apoptosis/necrosis).
constitutively
active NFkB
NFkB9=1 Prediction. Both death pathways are shut down in this mutant.
RIP1 deletion RIP19=0 RIPK12/2 MEFs are hypersensitivity to TNF, no
TNF-induced NFkB activation, [77].
Both survival and necrosis states become unreachable.
The effect of RIP1 silencing leads to a complete loss of the
decision process (apoptosis becoming the only outcome).
XIAP deletion C39=ATP AND MOMP No effect on TNF-induced toxicity in XIAP2/2 MEFs [78]. Behaviour similar to wild type.
z-VAD C39=0 FAS induced apoptosis is blocked, though cells can
undergo death by necrosis [79]. FAS activates NFkB [80].
Induction of autophagic cell death observed [81].
The simulation of z-VAD mutant is similar to the silencing of
caspase-8 (which implies that caspase-8 shut down in the
model seems to have some priority over caspase-3 shutdown).
z-VAD+RIP1
deletion
C39=0
C89=0
RIP19=0
Upon TNF cells treated with z-VAD-fmk that are
RIP-deficient cannot activate the NFkB pathway
anymore and die by necrosis [13].
The conjugated effect of RIP1 deletion and caspase inhibition
impedes the system to trigger any of the three pathways
(the ‘naı¨ve’ state becomes the only possible outcome).
doi:10.1371/journal.pcbi.1000702.t002
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number. In order to simulate each experiment, N trajectories were
generated, starting from the ‘‘physiological’’ condition with
TNF=1. At time td, the value of TNF is forced to zero. The
probabilities to reach the different phenotypes are then calculated
as explained in the Methods section. The average probabilities,
over the N computed trajectories, are represented in Figure 6, for
the wild type and the 15 mutants.
The purpose of this study is to investigate the dynamics of all the
mutants and how they reach the various possible phenotypes for
different lengths of TNF pulses. It provides a measurable way to
assess the appearance or disappearance of certain phenotypes
upon TNF induction. The curves of Figure 6 allow to link
explicitly the graphs of Figure 4 when TNF is ON (right panels)
and OFF (left panels) with the subjacent dynamics.
Let us compare the wild type case and the deletion of cFLIP as
an example of how to read these graphs. For early events, the two
cases behave similarly as expected (up to event 3). As TNF pulse is
prolonged, the apoptotic phenotype becomes more and more
pronounced and strongly favoured over the survival one in the
cFLIP mutant as opposed to the wild type conditions. This leads to
the complete disappearance of survival in the mutant. This
observation reinforces the role of cFLIP in the control of the
apoptotic pathway.
With the ‘ligand removal’ experiment, we can evaluate the
number of steps, in the reduced model, that are needed for the cell
to decide on its fate after TNF exposure. For almost all mutants
and wild type case, the choice is made around step 4. This means
that, after this point, even if TNF is removed, the cell has already
committed to a specific fate.
One surprise arises from the non-monotonic behaviour of
mutants for which apoptosis is suppressed (APAF1, BAX, caspase-
8 and FADD deletions and z-VAD-fmk treatment), tentatively
indicating a competition between components of the survival and
necrotic pathways. Indeed several inhibitory cross-talks could
explain this behaviour. These mutants also indicate the existence
of an optimal TNF induction for which the maximum rate of
necrosis is achieved (around step 2 in the corresponding mutants of
Figure 6).
A compact conceptual model
To complete our study of cell fate decision, we reasoned on the
simplest model of cell fate that can be deduced from the master
model described above.
The purpose here was to further simplify the network to obtain
a formal representation of the logical core of the network. We have
selected three components to represent the three cellular fates:
NFkB for survival, MPT for necrosis and CASP3 for apoptosis.
Based on reduction techniques and on the identification of all
possible directed paths between these three components [50], a
three-node diagram was deduced from the master model.
In this compact model, each original path (including regulatory
circuit) is represented by an arc whose sign denotes the influence of
the source node on its target. All original paths and the
corresponding arcs are recorded in Table 3. In some ambiguous
cases (e.g. influence of MPT on CASP3 or of NFkB on MPT), the
decision on the sign of the influence is based on the Boolean rules
and not on the paths only. Indeed, two negative and one positive
paths link NFkB to MPT. Therefore, the sign of the arc depends
not only on the states of BCL2 and of ROS, both feeding onto
MPT, but also on the rule controlling MPT value. Since the
Figure 4. Reachability of phenotypes starting from ‘‘physiological’’ initial conditions. The colours correspond to the phenotypes as
identified by the clustering algorithm (blue: ‘‘naı¨ve’’ survival state; green: survival through NFkB pathway; orange: apoptosis; purple: necrosis). Left
panel: TNF = FAS= 0, right panel: TNF = 1 and FAS= 0.
doi:10.1371/journal.pcbi.1000702.g004
NO INPUT TNF=1, FAS=0 FAS=1, TNF=0
Necrosis
SurvivalNaive Naive
Apoptosis
Figure 5. FADD mutant breaks the symmetry of TNF and FAS-
induced pathways. Activation of death receptors in FADD deletion
mutant leads to different cell fates depending on the values of TNF and
FAS.
doi:10.1371/journal.pcbi.1000702.g005
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absence of BCL2 and the presence of ROS (Boolean ‘AND’ gate)
participate in the activation of MPT, if BCL2 is active, then MPT
is set to 0, even when ROS is ON. By extension, if NFkB is ON,
then MPT is 0, justifying the choice for a negative influence. In the
case of mutations eliminating all the negative influences, however,
a positive arrow must be considered.
The resulting molecular network is symmetrical: each node is
self-activating and is negatively regulated by the other nodes
(Figure 7, upper left panel). This is a conceptual picture re-
presenting the general architecture of the master model that can
help address specific questions. Even for this relatively simple
regulatory graph, there is a finite but quite high number of possible
logical rules. For now, we use a simple generic rule involving the
AND and NOT operators. For example, the logical rule for
CASP3 is: NOT MPT AND NOT NFkB AND CASP3. This
compact model has four stable states, each corresponding to one
Figure 6. Ligand removal experiments. The x-axis represents the (discrete) duration of the TNF pulse td (see text). At each discrete time point
along the x-axis, the TNF signal is turned off. The different curves represent the average probabilities to reach the different attractors after the pulse
(the number of trajectories N= 2000). Curves are coloured in blue for naı¨ve state, green for NFkB survival, orange for apoptosis, and purple for
necrosis.
doi:10.1371/journal.pcbi.1000702.g006
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cell fate, along with the ‘naı¨ve’ state (Figure 7, upper right panel).
This is coherent with what was observed from the analysis of the
complete model.
To validate our compact model, we verified that the simulations
of known mutations correspond to the published observations.
Here, when a hidden component is deleted, all the paths traversing
this component in the original graph are broken. If all the paths
corresponding to an arc of the compact model happen to be
broken, then it is removed. In the case of auto-regulation, not only
the link is broken but the node is also set to zero to avoid the node
to become active in the absence of death receptor activation.
Let us consider the CASP8 deletion mutant to illustrate this
approach (Figure 7, middle panels). For this mutant, several
arrows in the compact model have to be deleted. For example, the
arcs CASP3)CASP3 (paths 4+5 in Table 3) and CASP3xMPT
(path 17) clearly depend on the activation of CASP8. Note,
however, that CASP8 intervenes in other paths, which do not fully
rely on its sole activity. In the case of the arc NFkB)NFkB,
CASP8 depletion interrupts path 3, while path 2 can still enable
the NFkB auto-regulation. Consistent with the results from the
previous section, CASP8 depletion leads to the loss of the
apoptotic fate while the ‘naı¨ve’ stable state cannot be attained.
At this point, one could wonder how apoptosis could be re-
established in a CASP8 mutant. The analysis of the broken paths
suggests some experiments to bypass CASP8 and undergo CASP3
activation. On the basis of path 4, BAX, MOMP, SMAC and
XIAP are identified as potential targets, while path 5 points to
cytochrome c and apoptosome. One way to experimentally assess
this possibility would be to inject exogenous cytochrome c as it was
done in ‘wild type’ conditions [51], or yet provoke its release from
the mitochondria by forcing the opening of the pores. This is
possible only in the absence (or with low activity) of NFkB and in
the presence of ATP. Again, since no quantitative information can
be deduced from the path analysis proposed in this study, no
prediction can be made on the concentrations of proteins needed
to achieve a specific answer.
In a previous section, we postulated that an inhibition of the
survival pathway by the necrotic pathway is necessary to
reproduce some mutant phenotype. We suggested that cIAP could
play this role. Let us now test this hypothesis with our conceptual
model. We build the corresponding 3-node model without cIAP.
In the current version, cIAP plays two important roles, first as a
mandatory intermediate in the inhibitory effect of MPT
(associated with necrosis) onto NFkB (survival) (path 13), next as
an obligate intermediate in the self-activation of NFkB (path 2).
The simulation (Figure 7, lower right panel) shows that in the
absence of cIAP, it is impossible to obtain the necrosis cell fate in
the CASP8 (and FADD) mutant(s), in agreement with our previous
conclusions and in support of our suggestion. A complete list of all
possible gene knockouts is provided in the Table S2.
This conceptual model analysis underlines the importance to
simplify in order to better understand the general structure of the
network and reason on it. Indeed, the simple 3-node network
enables us to grasp global functional aspects and propose specific
qualitative predictions.
Discussion
Mathematical models provide a way to test biological hypotheses
in silico. They recapitulate consistent heterogeneous published results
and assemble disseminated information into a coherent picture using
a coherent mathematical formalism (discrete, continuous, stochastic,
Table 3. List of paths corresponding to single arcs in the conceptual model of Figure 7.
Arc type Arc Paths on the regulatory graph
Sign of
regulation
Feedback circuits MPT)MPT 1) MPT)ROS)MPT (+)
NFkB)NFkB 2) NFkB)cIAP)RIP1ub)IKK)NFkB (+)
3) NFkB)cFLIPxCASP8xRIP1)RIP1ub)IKK)NFkB (+)
CASP3)CASP3 4) CASP3)CASP8)BAX)MOMP)SMACxXIAPxCASP3 (+)
5) CASP3)CASP8)BAX)MOMP)Cyt_c)apoptosome)CASP3 (+)
Other regulatory paths CASP3xNFkB 6) CASP3)CASP8xRIP1)RIP1ub)IKK)NFkB (2)
7) CASP3)CASP8)BAX)MOMP)SMACxcIAP)RIP1ub)IKK)NFkB (2)
8) CASP3xNFkB (2)
NFkBxCASP3 9) NFkB)cFLIPxCASP8)BAX)MOMP)Cyt_c)apoptosome)CASP3 (2)
10) NFkB)XIAPxCASP3 (2)
11) NFkB)XIAPxApoptosome)CASP3 (2)
12) NFkB)BCL2xBAX)MOMP)Cyt_c)apoptosome)CASP3 (2)
MPTxNFkB 13) MPT)MOMP)SMACxcIAP)RIP1ub)IKK)NFkB (2)
NFkBxMPT 14) NFkBxROS)MPT (2)
15) NFkB)BCL2xMPT (2)
16) NFkB)cFLIPxCASP8xRIP1)RIP1K)ROS)MPT (+)
CASP3xMPT 17) CASP3)CASP8xRIP1)RIP1K)ROS)MPT (2)
MPTxCASP3 18) MPT)MOMP)Cyt_c)apoptosome)CASP3 (+)
19) MPT)MOMP)SMACxXIAPxCASP3 (+)
20) MPT)MOMP)SMACxXIAPxapoptosome)CASP3 (+)
21) MPTxATP)apoptosome)CASP3 (2)
doi:10.1371/journal.pcbi.1000702.t003
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hybrid, etc.), depending on the questions and the available data.
Then, modelling consists of constantly challenging the obtained
model with available published data or experimental results (mutants
or drug treatments). After several refinement rounds, a model
becomes particularly useful when it can provide counter-intuitive
insights or suggest novel promising experiments.
Here, we have conceived a mathematical model of cell fate
decision, based on a logical formalisation of well-characterised
molecular interactions. Former mathematical models only consid-
ered two cellular fates, apoptosis and cell survival. In contrast, we
include a non-apoptotic modality of cell death, mainly necrosis,
involving RIP1, ROS and mitochondria functions.
Both the master and the reduced models were constructed on
the basis of an extensive analysis of the literature. The master
model (Figure 1A) summarises our current understanding of the
mechanisms regulating cell fate decision and identifies the major
switches in this decision. However, some important interactions,
components (caspase-2, calpains, AIF, etc.) or pathways (JNK,
Akt, etc.) have not yet been considered. This model was built to
be as generic as possible. Most of the mutants considered were
analysed in Jurkat cells, T-cells, or L929 murine fibrosarcoma
cells, thus in very different cellular contexts (e.g. in response to
TNF, Jurkat cells are resistant to cell death, whereas L929 cell
lines undergo necrosis). We are trying to account for all those
phenotypes in a unique model. The next step will be to provide a
model variant for each cell type in order to better match cell-
specific behaviours.
The reduced models can be used to simulate observed
experiments and to reflect on the general mechanisms involved
in apoptosis, survival or necrosis. This led us to identify the
principal actors involved in the decision process. The presence of
RIP1 or FADD, for example, proved to be decisive in our
simulation. However, the role of cFLIP appears less obvious than
previously suggested [7].
We can easily perturb the structure of the system in silico and
assess the dynamical effects of such perturbations (e.g. novel
knockouts). Our model can also be used to decide between
antagonist results found in different publications. For instance, the
inhibitory role of cIAP1/2 on the apoptotic pathway was initially
attributed to a direct inhibition of caspases. However, detailed
biochemical studies challenged this view [52,53]. We have tested
this hypothesis by adding an inhibitory arc from cIAP onto
CASP8, but simulations do not support a functional inhibitory role
of cIAP1/2, since survival is favoured over apoptosis in many
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Figure 7. Simplified view of the cell fate model structure. Left panels: compact regulatory graph deduced from the master model (top), along
with two variants (middle and low). Right panels: state transition graphs corresponding to each regulatory graph, using generic logical rules (cf. text).
Stable states are represented by ellipses (at the bottom of each state transition graph). Each stable state corresponds to one cell fate: 000 for the
‘naı¨ve’ state, 010 for survival, 001 for apoptosis, and 100 for necrosis. Top: wild type structure. Middle: CASP8 deletion mutant. Bottom: CASP8 deletion
mutant in the absence of cIAP.
doi:10.1371/journal.pcbi.1000702.g007
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mutants, thus making apoptosis a very improbable phenotype
(Figure S1). Similarly, we tested the role of the feedback circuit
involving CASP8 and CASP3. We found that the activation of
CASP8 by CASP3 is not functional when TNF and FASL are
constantly ON. However, when TNF or FAS signal is not
sustained, CASP3)CASP8 activation becomes necessary to
insure the persistence of the apoptotic phenotype. When TNF is
sustained, this feedback is no longer needed (see Figures S2 and S3
for details).
The in-depth analysis of model properties led us to propose
several predictions or novel insights. Some concern the structure of
the network, as several interactions appear to be necessary to
achieve specific phenotypes. For example, our simulations of
FADD and CASP8 deletion mutants underline the need for a
mechanism from the necrotic pathway that would inhibit the
survival one. Here, we consider a mechanism involving MPT,
SMAC and cIAP. Other simulations point to different roles of
proteins: RIP1 activity is transient in necrosis whereas it is
sustained in survival. Similarly, our model analysis shows the role
played by the duration of the TNF pulses in the cell fate decision
and enlights when this decision is made. Finally, some hints about
possible scenarios for forcing or restoring a phenotype in mutants
are provided.
Deregulations of the signalling pathways studied here can lead
to drastic and serious consequences. Hanahan and Weinberg
proposed that escape of apoptosis, together with other alterations
of cellular physiology, represents a necessary event in cancer
promotion and progression [54]. As a result, somatic mutations
leading to impaired apoptosis are expected to be associated with
cancer. In the cell fate model presented here, most nodes can be
classified as pro-apoptotic or anti-apoptotic according to the
results of ‘‘mutant’’ model simulations, which are correlated with
experimental results found in the literature. Genes classified as
pro-apoptotic in our model include caspases-8 and -3, APAF1 as
part of the apoptosome complex, cytochrome c (Cyt_c), BAX, and
SMAC. Anti-apoptotic genes encompass BCL2, cIAP1/2, XIAP,
cFLIP, and different genes involved in the NFkB pathway,
including NFKB1, RELA, IKBKG and IKBKB (not explicit in the
model). Genetic alterations leading to loss of activity of pro-
apoptotic genes or to increased activity of anti-apoptotic genes
have been associated with various cancers. Thus, we can cross-list
the alterations of these genes deduced from the model with what is
reported in the literature and verify their role and implications in
cancer.
For instance, concerning pro-apoptotic genes, frameshift
mutations in the ORF of the BAX gene are reported in .50%
of colorectal tumours of the micro-satellite mutator phenotype
[55]. Expression of CASP8 is reduced in ,24% of tumours from
patients with Ewing’s sarcoma [56]. Caspase-8 was suggested in
several studies to function as a tumour suppressor in neuroblas-
tomas [57] and in lung cancer [58].
On the other hand, constitutive activation of anti-apoptotic
genes is often observed in cancer cells. The most striking example
is the over-expression of the BCL2 oncogene in almost all follicular
lymphomas, which can result from a t(14;18) translocation that
positions BCL2 in close proximity to enhancer elements of the
immunoglobulin heavy-chain locus [59]. As for the survival
pathway, elevated NFkB activity, resulting from different genetic
alterations or expression of the v-rel viral NFkB isoform, is
detected in multiple cancers, including lymphomas and breast
cancers [60]. An amplification of the genomic region 11q22 that
spans over the cIAP1 and cIAP2 genes is associated with lung
cancers [61], cervical cancer resistance to radiotherapy [62], and
oesophageal squamous cell carcinomas [63].
A better understanding of the pro- or anti-apoptotic roles of
these genes involved in various cancers and their interactions with
other pathways would set a ground for re-establishing a lost death
phenotype and identifying druggable targets. The cell fate model
proposed here is a first step in this direction.
In the future, we will consider additional signalling cascades and
their cross-talks, following the path open by other groups [64]. In
parallel, we are contemplating the inclusion of other modalities of
cell death such as autophagy [65], which inhibits apoptosis
through BCL2 and is itself inhibited by apoptosis through Beclin1.
The functioning of the intrinsic apoptotic pathway and the
internal cellular mechanisms capable of triggering it could be
investigated in more details, taking advantage of recent molecular
analyses [66,67]. Finally, when systematic quantitative data
regarding the decision between multiple cell fates will become
available, our qualitative model could be used to design more
quantitative models adapted to specific cellular systems in order to
predict the probability for a given cell to enter into a particular cell
fate depending on stimuli.
Methods
Boolean formalism, synchronous vs. asynchronous
strategy
The computation of trajectories in the state space consists in the
calculation of sequences of states where each member of the
sequence is a logical successor of the previous one. As we choose to use
Boolean variables to encode the 25-dimensional master model, the
state space is the set S={0,1}25. Although finite, the size of this set is
huge (more than 33 millions states). Furthermore, in the discrete
framework, the mathematical definition of the trajectories assumes
an updating rule for the variables. Two main strategies are usually
considered to analyse discrete models of biological networks. The
first one consists in updating all variables simultaneously, at each
time step. This synchronous strategy [68] has the advantage to
generate simple determinist dynamics, each state having one and
only one successor. Drawing a directed arrow from each of the 225
states to its successor, one constructs the synchronous transition
graph, comprising all synchronous trajectories of the system. The
determinism of the synchronous transition graph is a very strong
property that poorly portrays the complexity of the biochemical
processes that are modelled (some processes are likely to occur faster
than others). The second strategy, which is used in this paper,
consists in considering that only one component is updated at each
time, implying that a state may have several successors [69].
More precisely, to compute the set of asynchronous successors
of a state x= (x1,…,xn)M{0,1}
n, one has to follow the three steps: (1)
compute the state F(x) = (f1(x),…, fn(x)), where fi is the Boolean rule
of the ith variable (F(x) is thus the synchronous successor of x); (2)
select the indices i such that xi?fi(x) (those are the indices of the
variables that are liable to change when the system is in state x);
and (3) for all such indices i, the state (x1,…,fi(x),…,xn) is an
asynchronous successor of x.
According to this definition, in the asynchronous approach, no a
priori hypothesis is made on the order of the events: all possible
orders are considered, which is much more satisfying from a
modelling point of view, as it is very difficult to know the relative
speeds of the different processes involved in the master model.
Note that the stable states of the model are independent on the
choice of the strategy (synchronous or asynchronous). Therefore,
the first analysis (based on the clustering of stable states) is valid
regardless the updating strategy.
Drawing an arrow from each state to its asynchronous
successors leads to the construction of an asynchronous transition
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graph, which comprises all possible asynchronous trajectories of
the system. To each arrow starting from the same state is
associated an equal probability (see [70] for details). This is a
strong assumption, which is the main reason why the exact values
of computed probabilities (of the different phenotypes) should not
be compared to experimental data in a quantitative manner.
Nevertheless, the same assumption has been made for all model
variants (mutants and drug treatments), thereby allowing compar-
ative studies. A systematic method to assess the impact of the
probability distribution is a key point towards a finer quantitative
analysis (work in progress).
As pointed earlier, the size of the transition graph is exponential
with respect to the number of variables, which constitutes a first
obstacle to the dynamical analysis. A second difficulty resides in
the fact that the asynchronous graph is not deterministic, as each
vertex may have more than one successor, which, given the size of
the graph, makes the application of classical graph algorithms
computationally heavy.
Model reduction
We have used a model reduction technique specifically adapted
to discrete systems, which mainly consists in iteratively ‘‘hiding’’
some variables, while keeping track of underlying regulatory
processes [47]. The main dynamical properties of the master
model, including stable states and other attractors are conserved in
the reduced model. Thanks to the computation of the reduced
asynchronous transition graph, relevant qualitative dynamical
properties of the model can be compared to experimental results
for wild type and in different mutant cases.
To reduce the number of species in the master model, each
logical rule is considered. For each removed component, the
information contained in its rule is included in the rules of its
targets such that no effective regulation is lost.
Many intermediate components could easily be replaced by a
proper rewriting of the logical rules associated with their target
nodes. For example, IKK has only one input (RIP1ub) and one
output (NFkB). Since its role in our model merely consists in
transmitting the signal from RIP1ub to NFkB, it can be easily
replaced by a straightforward change in the logical rule associated
with NFkB (implementing a direct activation from RIP1ub
instead of IKK). We also relied on the results of the clustering of
stable states and their associations with biologically plausible
phenotypes to select the key components to keep in the reduced
model: NFkB is the principal survival actor, while caspases-3 and
-8, together with the mitochondrial membrane permeability
variables (MOMP and MPT), determine apoptotic and non-
apoptotic cell deaths.
Let us consider the example of the removal of BAX and BCL2
(Figure 1 A and B). The regulators (or inputs) of these variables are
NFkB for BCL2 and CASP8 for BAX while their regulating
targets (or outputs) are MPT for BCL2 and MOMP for BAX.
BCL2 is directly activated by NFkB, and has two targets: MPT
and BAX. Therefore, BCL2 removal is performed by replacing
BCL2 by NFkB into the rules of the two targets, leading to the two
new logical rules: MPT9=ROS AND NOT NFkB and
BAX9=C8 AND NOT NFkB. Applying the same process to
remove BAX, one obtains the following new rule for MOMP:
MOMP9=MPT OR (C8 AND NOT NFkB).
The variables MOMP and MPT have now as inputs the
variables NFkB and CASP8. One can see that, in spite of the
disappearance of variables BAX and BCL2, their regulating roles
are still indirectly coded in the reduced system, ensuring that no
‘‘logical interaction’’ of the master model (i.e. activation or
inhibition) is actually lost during the reduction process. Table S3
lists the variables of the master model that are removed to obtain
the reduced model.
Some hypotheses were made when reducing the model. First,
FADD is considered to be constantly ON in wild type simulations.
Second, since the two complexes TNFR and DISC-TNF have
been removed together with the input FADD, the two deaths
ligands TNF and L have the exact same action in the reduced
model. Indeed, we consider that, in response to FAS death
receptor engagement as well as that of TNF; the activations of
both the survival and necrotic pathways RIP1-dependent. In this
case, one could then merge these variables and consider only one
input that could be called ‘‘external death receptor’’. However, we
choose to keep the two variables TNF and FASL, in the FADD
deletion mutant, the phenotype differs for TNF and FAS signal:
actually, only for that mutant is the symmetry of TNF and FAS
broken.
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